DelveInsight Blogs Sitemap

All Posts in this category
S.No. Product Name Actions
1 Suneva Medical-Viveon Health merger update; Smith+Nephew acquires Engage Surgical; Abiomed's preCARDIA technology; Medtronic’s DTM Spinal Cord Stimulation; Endo Tools Therapeutics’s Endomina System; Diadem's AlzoSure predict prognostic blood test Visit Post
2 Leman Micro Devices’ e-Checkup system; Calon Cardio-Technology & Leviticus-Cardio announced Breakthrough; Alcon buys Ivantis; Medtronic to acquire Affera; Abiomed’s Impella 5.5 with SmartAssist; Abbott’s EnSite X EP System with EnSite OT Visit Post
3 Siemens Healthineers’s COVID-19 Antigen Self-Test; Paragon’s R3ACT Stabilization System; Pulnovo Medical’s PADN-CFDA trial; Endotronix’s PROACTIVE-HF trial; Abbott’s Proclaim XR SCS System; RTI Surgical spins off businesses Visit Post
4 Sky Medical’s Geko™ device; Fist Assist Devices obtains Breakthrough Device designation; Edwards obtains FDA approval; BD launched instrument for testing; GE acquires BK Medical; Zynex’ CM-1500; Foldax’s TRIA biopolymer heart valve Visit Post
5 Edwards’ Sapien 3 with Alterra Prestent; Koios Medical’s breast, thyroid cancer-spotting AI; Lineage Collaborates with Genentech; Novartis, BeiGene ink deal Visit Post
6 BrainQ's EMAGINE Trial; AtaCor's EV-ICD study; Urotronic's Optilume Urethral Drug-Coated Balloon approval; Medtronic receives 510(k) clearance; Baxter acquires Hillrom Visit Post
7 Boston Scientific's MODULAR CRM System; Restore Medical's ContraBand clinical trial result; BD acquires Venclose; Roche differentiates mutations in Omicron; Linus's StrandDx-ASD; HelioLiver launches liquid biopsy test Visit Post
8 LensGen’s Juvene Intraocular Lens; Nevro announces clinical data publications; FDA Clearance to Immunexpress’s SeptiCyte; GE unveils AI and Digital Technologies; Canon launches PIQE DLR and SilverBeam; Hyperfine’s Swoop gets FDA clearance Visit Post
9 Abbott's Pacemaker System; Ivantis’s Hydrus Microstent; Medtronic’s PillCam Small Bowel 3; ALung Technologies's Hemolung; AppliedVR’s EaseVRx; J&J to split into two companies; OrthAlign’s Lantern® launch; LumiThera’s Light-based Theranostic Visit Post
10 AstraZeneca-Moderna's AZD8601 VEGF-A mRNA Trial; Wision AI gets CE Mark approval; Getinge acquires Verrix; LumiThera buys Diopsys Visit Post
11 TecTraum’s pro2cool receives Breakthrough Device Designation; Vektor Obtains FDA Clearance for vMap; Medtronic’s TMVR system; Sight Sciences's PRECISION Trial; Alcon to buy Ivantis; Philips to acquire Cardiologs Visit Post
12 Alcon to acquire Ivantis; Philips to takeover Cardiologs; Flunked cancer drug progresses in I-O in pancreatic cancer models; Indigo system CAT RX catheter meets primary endpoint in trial Visit Post
13 Smith+Nephew's LEGION CONCELOC; Renew Bioscience's Cerezen; Perimeter Medical's ATLAS AI Project; SAGA Diagnostics-AZ's Deal; Magnus Receives Breakthrough Device Designation; ReValve's Transeptal Mitral Valve Replacement Visit Post
14 Mapping the Increasing Burden of Heart Failure: What Does it Bring for Healthcare Market Companies? Visit Post
15 Amber Implants VCFix spinal system; iotaMotion's iotaSOFT Insertion System; Boston Scientific acquires Baylis; ReCor's Paradise Ultrasound Renal Denervation; Boston Scientific's Ranger Drug-Coated Balloon; Natera's Prospera Visit Post
16 Analyzing the Key Opportunities & Challenges in the Nutraceuticals Market Visit Post
17 Increasing Incidence, Influx of Companies add to the Market Revenue in the Myocardial Infarction Market Space Visit Post
18 Roche inks $3B deal; Owlstone raises $58M; FDA approves OCS heart system; Google, Mayo Clinic build brain-mapping AI algorithm Visit Post
19 Abiomed’s Impella ECP; Helius’s PoNS Device; Smart Meter’s iGlucose BGM; XACT’s CT-Guided Percutaneous Procedures; BD’s Veritor At-Home COVID-19 Test; Delfi’s Liquid Biopsy Visit Post
20 Venous Thromboembolism Market Growth Quadrant to Balloon Up Visit Post
21 Boston Scientific’s EkoSonic; FDA clearance for EXALT; Kestra Medical’s ASSURE; ZOLL Next-Generation remedē system; CytoSorbents' DrugSorb-ATR; Fujifilm-Lunit collaboration Visit Post
22 New Approaches and Evolutions to Reshape the Diabetes Management and Care Visit Post
23 Nevro's Spinal Cord Stimulation; Boston's PINNACLE FLX; NuVasive's Modulus ALIF; J&J's VERITAS Vision System; Medtronic's DCB Catheter; AngelMed's Heart Attack Warning System Visit Post
24 With advancements in Innovative Technology, Cardiac Monitoring Devices Market is Booming Significantly Visit Post
25 MedTech Market Industry: Approval of Devices, Therapy Address Market Needs | Clinical Outcomes Create New Value Visit Post
26 Intellia's Quest with CRISPR; Innovent, Synaffix ADC Tech Deal; Lilly's Diabetes Blockbuster Tirzepatide; Polyphor’s Bleak Future Visit Post
27 What Factors are Shaping the Trends in the Implantable Cardiac Monitors Market? Visit Post
28 Insilico Medicine raises $255M; Sanofi & Translate Bio initiate trial; Medtronic gains expanded FDA approval; Blackstone, Cellex & Intellia form CAR-T startup Visit Post
29 Mallinckrodt earns FDA nod for skin therapy; RayzeBio secures $108M; VectorY raises $38M; Umoja banks $210M Visit Post
30 Eclipse, Medtronic, Aethlon, Cognoa, ObvioHealth, and others Continue to Veer MedTech Market Forward Visit Post
31 Medical Devices Market Blooms as the Key MedTech Companies Continue to Bring-In Innovation Visit Post
32 Continuous R&D Ramps Up the Pacemakers Pipeline Landscape, New Devices To Enter the Market Soon Visit Post
33 MedTech Industry Roars Back as FDA Approvals Soar Visit Post
34 Arch Oncology scores $105M; Abbott’s new coronary imaging platform; Lilly scraps IL-23 psoriasis program; Biogen offer access to experimental ALS med Visit Post
35 Ever-Evolving Market Landscape of Transcatheter Aortic Valve Replacement Visit Post
36 How Fitness Trackers Are Shaping the Future of Healthcare? Visit Post
37 Navigating Through the Treatment Market Landscape of Head and Neck Cancers Visit Post
38 Diagnosing At-Home: Are At-Home Diagnostic Tools The New Trends? Visit Post
39 Healthcare in 2021: Top Disruptions Bound To Impact The Way Healthcare Is Delivered Visit Post
40 The Mesh of the Generics and the Potential of Emerging Therapies in the Smoking Cessation Market Visit Post
41 Gilead and Vir collaborate; Tessera scores $230M; Teladoc & Dexcom bring CGM Tech; Verve unveils lead candidate Visit Post
42 Medical Tourism: Road to Affordable and Quality Medical Care Visit Post
43 Pfizer/ OPKO Health’s Somatrogon; FDA EU for SCONE device; Antengene ATG-010 for rrMM and rrDLBCL; SanBio STEMTRA Phase 2 Interim Results Visit Post
44 Top 10 Most Promising Drugs In The Amyotrophic Lateral Sclerosis Treatment Landscape Visit Post
45 Treating Patients with Software: Digital Therapeutics Visit Post
46 Will Wearable Devices be Streamlined in Healthcare? Visit Post
47 Creating Future of MedTech Industry with Artificial Intelligence Visit Post
48 The State of Alternative Medicine In The Healthcare Visit Post
49 Healthcare Delivery System: What lies in the future? Visit Post
50 Boehringer Ingelheim; Roche demonstrated new analyses of their drugs in patients with ILDs during the American Thoracic Society (ATS) Virtual conference Visit Post
51 Rejections and Withdrawals: Familial Chylomicronemia Syndrome Market Needs a Therapy Effective Enough, Affordable Enough Visit Post
52 Olema raises $54M; T3 Pharma bags $27M to advance bacterial cancer therapy program; Biofourmis and Chugai's Collaboration; A new study on averting heart attack Visit Post
53 What are the Top Five Leading Causes of Deaths in the World? Visit Post
54 With the Advances in Regenerative Therapy to Offer Curated Treatment Options, Off-label Therapy Market is Set to Decline for Dilated Cardiomyopathy Visit Post
55 Precision Medicine: An emerging approach to conventional treatment Visit Post
56 Mavacamten Phase III clinical trial, FDA nod for Ovarian cancer therapy, Dyno Therapeutics & Novartis Collaboration, Abbott's COVID-19 diagnostic kit Visit Post
57 Telemedicine: Can it be the future of healthcare? Visit Post
58 Ofev’s expanded use; Arkin Bio-Ventures II launch; USD 125 M for COVID-19 treatment Visit Post
59 Top healthcare innovations changing the healthcare dynamics Visit Post
60 Booming Healthcare sector in MENA: Lucrative opportunity for Global pharma players Visit Post
61 Cardiovascular Disease: A major cause of health loss and a global burden Visit Post
62 Potential of Digital therapeutics and increasing CVDs Visit Post
63 Acceleron Pharma's drug sotatercept touches the phase 2 mark; GT Medical receives nod for GammaTile; New treatment strategy for Parkinson's disease Visit Post
64 Tepezza receives approval; a new way to treat Alzheimer’s Visit Post
65 Polypills: Can they offer a potential approach to treat CVDs? Visit Post
66 Reversing Ischemia with Gene therapy Visit Post
67 FDA approval to AZ’s Farxiga for heart failure; GSK divests two travel vaccines to Bavarian Nordic; New breakthrough therapy for Cystic Fibrosis Visit Post
68 FDA approves Ofev for interstitial lung disease Visit Post
69 Helsinn out licenses Pracinostat in South America Visit Post
70 Juvenescence nets USD 100M; Sarepta DMD drug faces rejection Visit Post
71 Recursion Pharmaceuticals nets USD 121M; Bayer's MRI agent gets a nod Visit Post
72 Pulmonary Arterial Hypertension Therapies Visit Post
73 World Hypertension day Visit Post
74 Notizia Visit Post
75 Approach for Cystic Fibrosis; An alternative for Statins; Oral medications not safe; Carbon monoxide poisoning treatment gets approval Visit Post
76 Sage’s drug meets phase 3; Blocking 2 key pathways help in tackling TNBC; FDA clears Paragonix; FDA gives a nod Visit Post
77 Notizia Visit Post
78 WORLD HEART DAY | 29-09-2018 Visit Post
79 Notizia Visit Post
80 Notizia Visit Post
81 Commercial Visit Post
82 Key Clinical Outcomes- 30/07/2018 Visit Post
83 NF-κB Inhibitors- A Promising Future Visit Post
84 Cholesterol drug Praluent successful in reducing heart risk Visit Post
85 December 7 Business Cocktail Visit Post
86 Chemists may help solve the air-pollution health crisis Visit Post
87 AstraZeneca and Incyte Collaborate; Tocagen’s therapy; FDA warns companies;FDA Revokes Visit Post
88 Novo petitions FDA;J&J invests; Xarelto’s trial; Roche's Tecentriq Visit Post
89 Thrombolytic Sciences’ trial; NurOwn for ALS; Biosimilar receives approval; Trelegy Ellipta for the treatment of COPD Visit Post
90 Cannabidiol trial; MyoKardia aims; LDL drug data Visit Post
91 Sanofi invests; ICER pitches; $6M in NIH; Pfizer, Roche cancer drug pricing Visit Post
92 Lilly moves ahead; Authorities raid; Bristol-Myers, AZ in legal; PhRMA expected to weed out Visit Post
93 Merck’s Keytruda sales; Valeant on name change; Pfizer – BMS; Amgen puts Repatha outcomes for deal Visit Post
94 Medical tourism in India Visit Post
95 AMRI enters alliance; Ferring and Enteris deal; Quotient Clinical Acquires; Renova takes over Rights Visit Post
96 mTOR Inhibitors-Emerging therapy in various therapeutic areas Visit Post
97 Sanofi, Regeneron one step closer; Pharma's deal; J&J and Actelion deal Visit Post
98 Angina Pectoris : Manifestation of Coronary Artery Disease Visit Post
99 Glaxo replaces ViiV; Lilly nets; AstraZeneca shuffles off; Gazyva aims to beat Visit Post
100 Neprilysin Inhibitor for Cardiovascular Diseases Visit Post
101 Sun Pharma Announces Launch; OptiNose files; Opiant obtains rights; Swissmedic approves Visit Post
102 Bayer Partners with DelSiTech to Develop; Amgen and Arrowhead Announce; Allergan, AstraZeneca’s deal; Lexicon Pharma announces deal Visit Post
103 Sun Pharma forms partnership; Pfizer and DCRI collaborate; Avara Acquires AZ; ASLAN Pharmaceutical’s Collaboration; Amgen and Servier partnership Visit Post
104 Anticoagulants (VTE & AF) Therapeutics Market Visit Post
105 Global atrial fibrillation market is expected to grow to $12.5 billion by 2020 Visit Post
106 Global VTE market is expected to grow to $4.75 billion by 2020 Visit Post
107 Anticoagulants-Market Insights; Drugs Sales Forecast (VTE & AF) Visit Post
108 New Approach Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors Visit Post
109 DelveInsight launches Indication Active Pharmaceutical Ingredient (API) Reports Visit Post
110 Outbreak of Companies Challenging New Pathways for Treatment of Pulmonary Arterial Hypertension Visit Post
111 DelveInsight’s Cardiovascular disorders based Gene Therapy Reports Visit Post